Preclinical manifestations of organ damage associated with the metabolic syndrome and its factors in outpatient children

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 611-615

  Di Bonito, Procolo ^a   Moio, Nicola ^a   Scilla, Carolina ^a   Cavuto, Luigi ^a   Sibilio, Girolamo ^a   Forziato, Claudia ^a   Sanguigno, Eduardo ^a   Saitta, Francesco ^a   Iardino, Maria Rosaria ^a   Capaldo, Brunella ^b  

^a Pozzuoli Hospital   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Alanine aminotransferase; Cardiometabolic risk factors; Glomerular filtration rate; Left ventricular mass; Microalbuminuria; Pediatric metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE;

ARTICLE; BODY WEIGHT; CHILD; DISEASE ASSOCIATION; FEMALE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OUTPATIENT; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ALANINE TRANSAMINASE; ALBUMINURIA; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LIVER DISEASES; MALE; METABOLIC SYNDROME X; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 78649743985     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.017     Document Type: Article

References (31)

1. Daniels S.R., Arnett D.K., Eckel R.H., et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999-2012.
2. Tailor A.M., Peeters P.H., Norat T., Vineis P., Romaguera D. An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Pediatr Obes 2010, 5:202-213.
3. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072.
4. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403-414.
5. Watanabe S., Yaginuma R., Ikejima K., Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol 2008, 43:509-518.
6. Bianchi C., Penno G., Daniele G., et al. The metabolic syndrome is related to albuminuria in type 2 diabetes. Diabet Med 2008, 25:1412-1418.
7. Lucove J., Vupputuri S., Heiss G., North K., Russell M. Metabolic syndrome and the development of CKD in American Indians: the strong heart study. Am J Kidney Dis 2008, 51:21-28.
8. Aijaz B., Ammar K.A., Lopez-Jimenez F., et al. Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. Mayo Clin Proc 2008, 83:1350-1357.
9. Li S., Chen W., Srinivasan S.R., Berenson G.S. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa heart study. Atherosclerosis 2005, 180:349-354.
10. Steinberger J., Daniels S.R., Eckel R.H., et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American heart association atherosclerosis, hypertension, and obesity in the young committee of the council on cardiovascular disease in the young; council on cardiovascular nursing; and council on nutrition, physical activity, and metabolism. Circulation 2009, 119:628-647.
11. Urbina E. Noninvasive assessment of target organ injury in children with the metabolic syndrome. J Cardiometab Syndr 2006, 1:277-281.
12. Di Bonito P, Forziato C, Sanguigno E, Di Fraia T, Saitta F, Iardino MR, Capaldo B. Prevalence of the metabolic syndrome using ATP-derived definitions and its relation to insulin-resistance in a cohort of Italian outpatient children. J Endocrinol Invest 2010 Mar 10. [Epub ahead of print].
13. Di Bonito P., Forziato C., Sanguigno E., et al. Prehypertension in outpatient obese children. Am J Hypertens 2009, 22:1309-1313.
14. Schwartz G.J., Muñoz A., Schneider M.F., et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009, 20:629-637.
15. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
16. Chinali M., de Simone G., Roman M.J., et al. Impact of obesity on cardiac geometry and function in a population of adolescents. The strong heart study. J Am Coll Cardiol 2006, 47:2267-2273.
17. Matteucci M.C., Wühl E., Picca S., et al. ESCAPE Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006, 17:218-226.
18. Krumholz H.M., Larson M., Levy D. Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 1995, 25:879-884.
19. Cacciari E., Milani S., Balsamo A., et al. Italian cross-sectional growth charts for height, weight and BMI (2-20 yr). J Endocrinol Invest 2006, 29:581-593.
20. Cook S., Auinger P., Huang T.T. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr 2009, 155(S6):e15-26.
21. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576. National high blood pressure education program working group on high blood pressure in children and adolescents.
22. Schwimmer J.B., Dunn W., Norman G.J., et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010, 138:1357-1364.
23. Gross J.L., de Azevedo M.J., Silveiro S.P., et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176.
24. Chinali M., de Simone G., Roman M.J., et al. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol 2008, 52:932-938.
25. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 18(346):1221-1231.
26. Schindhelm R.K., Dekker J.M., Nijpels G., et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007, 191:391-396.
27. Di Bonito P., Sanguigno E., Di Fraia T., et al. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism 2009, 58:368-372.
28. van Vliet M., von Rosenstiel I.A., Schindhelm R.K., et al. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr 2009, 168:585-591.
29. Park H.S., Han J.H., Choi K.M., Kim S.M. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005, 82:1046-1051.
30. Invitti C., Maffeis C., Gilardini L., et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) 2006, 30:627-633.
31. Nguyen S., McCulloch C., Brakeman P., Portale A., Hsu C.Y. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 2008, 121:37-45.